Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

Lilly is using a new line of attack against telehealth firms, accusing them in lawsuits of engaging in the corporate practice ...

Amid a measles outbreak and a government response led by a health secretary who has repeatedly cast doubt on the safety and ...

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

Claims about the link between measles vaccines and autism, and about treatments for measles, appear to be more widely heard, ...

Improv skills can make interactions between people with dementia and their care partners more enjoyable for everyone.

The Trump administration seems to believe that some words and ideas fail an ill-posed and completely nonscientific test of ...

Yes, the hype around AI in medicine is breathless. But look at the reality. New transcription technology is becoming routine for doctors’ visits. Drug companies use AI to optimize the creation ...

The Women's Health Initiative, the enormous study that shaped treatment of menopause and other conditions, is on the verge of ...

Food companies have voluntarily consented to getting rid of the artificial dyes, Makary said, but there is currently no ...

The new schizophrenia drug didn’t provide additional benefits when given on top of standard-of-care therapy, Bristol Myers ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...